The Solana Foundation has introduced Microscope, an open-source tool that converts confirmed transactions from Solana programs into decoded records, dashboards, and alerts within users' own environments. Operators connect their programs via gRPC streams or RPC endpoints, allowing Microscope to decode instructions and events using the program's interface definition language. It sends structured data to Loki and Prometheus, with dashboards and alert rules managed through Grafana. Users can set alerts for specific transaction details and receive notifications via Slack, Telegram, or PagerDuty. The tool also monitors its own data pipeline for issues. Importantly, deployments are self-hosted by operators, with no data sent to the Solana Foundation.
Solana Foundation's new Microscope tool is the subject, with Pluang market data providing context. As of Nov 05, 2026 03:51 WIB, 42 of 50 major cryptocurrencies rose while 7 fell on Pluang. Notable movers include SXP down 46.27% at Rp37, BAL up 11.14% at Rp16.297, and BAT up 8.32% at Rp2.486 with 83% sell activity.
NOVAGOLD shareholders approved a transaction for New NOVAGOLD to acquire the remaining 40% interest in the Donlin Gold project from Paulson Advisers, increasing NOVAGOLD's ownership from 60% to 100%. This consolidation makes New NOVAGOLD the ultimate...
Fox Factory Holding Corp. has appointed Troy Henige as its new Chief Technology Officer (CTO) to lead the company's technology vision, strategy, and product roadmap. This new role aims to enhance innovation, connect engineering strengths across the c...
3M Company has reached a historic $7.35 billion settlement to resolve personal injury claims related to exposure to PFAS, toxic chemicals known as "forever chemicals." The settlement covers about 99% of existing claims, potentially benefiting 115,000...
The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North A...
Royalty Pharma plc is the global leader in acquiring biopharmaceutical royalties, focusing on de-risked, post-proof-of-concept assets. The company offers investors exposure to blockbuster therapies with attractive risk-adjusted returns, including aro...
